{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P10145",
      "entity_text" : "IL-8",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q10981",
      "entity_text" : "SE",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "SE treatment reduced the salivary concentration of IL-6 from 0.052 +/- 0.030 ng/mL (n = 5) to 0.01 ng/mL and that of IL-8 from 5.25 +/- 1.06 ng/mL (n = 5) to 1.11 ng/mL [XREF_BIBR].",
  "reading_complete" : "2020-08-05T22:05:22Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T21:50:24Z",
  "trigger" : "reduced",
  "evidence" : [ "SE treatment reduced the salivary concentration of IL-6 from 0.052 +/- 0.030 ng/mL (n = 5) to 0.01 ng/mL and that of IL-8" ],
  "pmc_id" : "6473826",
  "score" : 0
}